Home/Modiblast Pharma/Prof. Dr. Helga Schmetzer
PD

Prof. Dr. Helga Schmetzer

Founder, CEO, CSO

Modiblast Pharma

Therapeutic Areas

Modiblast Pharma Pipeline

DrugIndicationPhase
MB101Acute Myeloid Leukemia (AML) - Maintenance TherapyPre-clinical